300357.SZ Stock Analysis
30
Attractive
Based on Eyestock quantitative analysis, 300357.SZ`s fundamental data and valuation indicate an investment grade of Attractive at the current time.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
High score
Upside
To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.
Greatly undervalued
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of biopharmaceutical products. The company is headquartered in Huzhou, Zhejiang and currently employs 1,488 full-time employees. The company went IPO on 2014-01-21. The firm's main products include Dermatophagoides Farinae Drops and Dermatophagoides Farinae Skin Prick Diagnostic Kits. The firm's products are primarily used for the treatment of allergic rhinitis caused by dust mite allergy, the desensitization of allergic asthma and the in-vivo diagnosis of dust mite drops. The firm distributes its products in domestic market.